About
Allakos, Inc. is a clinical-stage biopharmaceutical company developing antibodies that target receptor molecules on immune effector cells implicated in allergy, inflammation, tissue damage, and proliferative disorders.
Explore Allakos, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.